SPHEBIO
Latest round
- Series A
Last raised
- Aug 2023
Total raised
- $3.4M
Investors
- 4
About SPHEBIO
SPHEBIO, founded in 2020 in Pohang, South Korea, is dedicated to developing biomimetic materials.SPHEBIO specializes in the development of innovative biomimetic materials through advanced three-dimensional (3D) cell culture technology. Their core product offerings are centered around creating biomaterial production processes that mimic the natural behavior of living organisms, thereby addressing critical needs in the biomedical industry. Their applications are geared towards enhancing tissue modeling and regenerative medicine, with a particular focus on the pharmaceutical sector. The company's products are utilized by a diverse clientele that includes research institutions, pharmaceutical companies, and healthcare providers across markets in North America, Europe, and Asia.SPHEBIO's revenue model primarily revolves around B2B transactions with pharmaceutical companies and research institutions. SPHEBIO supplies its proprietary SPHRINTER equipment, which facilitates the production of 3D cell models, along with necessary GMP documentation and quality control standards. The company is targeting expansion into North American and European markets by the end of 2024.
Who invested in SPHEBIO
4 investors across 1 round
See all investors in SPHEBIO
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Aug 23, 2023
Amount
$3.4M
Investors
Questions about SPHEBIO
Who invested in SPHEBIO?
SPHEBIO has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SPHEBIO raised?
SPHEBIO has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SPHEBIO last raise money?
SPHEBIO's most recent round on record is a Series A, in Aug 2023.
What does SPHEBIO do?
SPHEBIO, founded in 2020 in Pohang, South Korea, is dedicated to developing biomimetic materials.
Where is SPHEBIO headquartered?
SPHEBIO is headquartered in Pohang, South Korea.
Which VCs invest in companies like SPHEBIO?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at SPHEBIO's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like SPHEBIO? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.